Sign In
Buy RXST
$4.79
-0.150 (-3.04%)
At Close: Jun 03, 2026
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In RxSight (RXST) To Contact Him Directly To Discuss Their Options
SAN DIEGO, July 15, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating RxSight, Inc. (NASDAQ: RXST) to determine whether certain RxSight, Inc. officers and directors vi
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) on behalf of investors concerning the Co
INVESTOR ALERT: Investigation of RxSight, Inc. (RXST) Announced by Holzer & Holzer, LLC
03:10pm, Friday, 11'th Jul 2025
ATLANTA, July 11, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) complied with federal securities laws. On Ju
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of RxSight, Inc. (“RxSight
Johnson Fistel Begins Investigation on Behalf of RxSight, Inc. (RXST) Shareholders
10:12am, Friday, 11'th Jul 2025
SAN DIEGO, July 11, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether RxSight, Inc. (NASDAQ: RXST), or any of its executive officers, violated federal
RxSight, Inc. (RXST) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
09:00am, Friday, 11'th Jul 2025
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) investors concerning the Compan
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) on behalf of investors concerning the Com
Crude Oil Moves Higher; RxSight Shares Plunge
01:33pm, Wednesday, 09'th Jul 2025
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Wednesday.
U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Wednesday.
RxSight, Inc. Announces Preliminary Second Quarter 2025 Revenue and Revised 2025 Guidance
04:05pm, Tuesday, 08'th Jul 2025
ALISO VIEJO, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients followin
FMS vs. RXST: Which Stock Is the Better Value Option?
12:41pm, Friday, 04'th Jul 2025
Investors looking for stocks in the Medical - Instruments sector might want to consider either Fresenius (FMS) or RxSight, Inc. (RXST). But which of these two companies is the best option for those lo
FMS or RXST: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 18'th Jun 2025
Investors looking for stocks in the Medical - Instruments sector might want to consider either Fresenius (FMS) or RxSight, Inc. (RXST). But which of these two companies is the best option for those lo
RxSight: Valuation Blowout Creates Opportunity
09:32am, Saturday, 07'th Jun 2025
RxSight is a promising growth stock in the medical device sector, focusing on innovative cataract treatments with a large addressable market. Despite a recent decline, RxSight's high margins and scala
RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum
04:10pm, Tuesday, 20'th May 2025
ALISO VIEJO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients followin
